About
Asher Nathan has extensive biotech operating experience, having started biotech companies, Intelligene and EvoRx, both of which were formed around technologies which he invented. Intelligene was a pioneering biotech company which dealt with molecular evolution and successfully attracted venture capital from top international venture firms including Walden Investments, Advent and Rothschild Venture Capital. The technology was acquired by Genetico. EvoRx was founded together with Nobel Prize Winners Arthur Kornberg and Roger Kornberg, and Jim Manuso, who was subsequently CEO of several successful publicly traded biotech companies, including Supergen. Dr. Nathan has authored over 25 patents in the field of biotechnology. Prior to co-founding Predictive Therapeutics, Dr. Nathan co-founded Zoticon Bioventures where he served as Managing Partner. Before that, Dr. Nathan served as a Managing Director at Paramount Biocapital, a top rated venture fund for in-licensing biotechnology transaction
Position in the VCSift Database
- • 3,360 investors hold the CEO role in VCSift. Asher Nathan is one of them.
- • 610 investors are based in Israel.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Israel
Contact Information
Find more investors like Asher
Search Investors